Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube

Hematology / Oncology CE Activities

Hematology / oncology blog

View Details

Targeting BCMA: A New Path in Relapsed/Refractory Multiple Myeloma

In triple- and quad-refractory myeloma, median survival was only about 9 months, and less than 6 months in penta-refractory disease.
  • Hematology / Oncology
  • Blog
DOWNLOAD
View Details

Navigating Immunotherapy in Advanced NSCLC: What Every Oncologist Should Know

The advent of immunotherapy has significantly extended survival and revolutionized care in advanced non-small cell lung cancer (NSCLC).
  • Hematology / Oncology
  • Blog
DOWNLOAD
View Details

Is Immunotherapy Right for Your Patient with Nonmelanoma Skin Cancer?

The primary goal of treatment in nonmelanoma skin cancer (NMSC) is tumor elimination with maximal preservation of function and cosmesis.
  • Hematology / Oncology
  • Blog
DOWNLOAD

RMEI Presentations

RMEI DECISION SUPPORT AIDS

View Details

Intravitreal Anti-VEGF & Bispecific Therapies for DME & nAMD

In late 2022, the ocular implant, insertion tool assembly, (including the drug vial & initial fill needle) for ranibizumab PDS were voluntarily recalled due to septum dislodgement and paused implantations including ongoing global clinical trials; this did not include the refill vial and needle.
  • Hematology / Oncology
  • Decision Support Aid
DOWNLOAD
View Details

Cervical Cancer: What You Need to Know About Screening, Symptoms, and Treatments

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. An estimated 13,960 women are diagnosed with invasive cervical cancer every year.
  • Hematology / Oncology
  • Decision Support Aid
DOWNLOAD
View Details

Seeing Nonmelanoma Skin Cancers Through A New Lens: The Role and Place of Immunotherapy

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.
  • Hematology / Oncology
  • Decision Support Aid
DOWNLOAD
View Details

Relapsed or Refractory Chronic-Phase: CHRONIC MYELOID LEUKEMIA (CML)

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.
  • Hematology / Oncology
  • Decision Support Aid
DOWNLOAD

LATEST HEMATOLOGY / ONCOLOGY ARTICLES

RSS Latest Hematology / Oncology Articles
  • Clearing the Smoke on Fossil Fuels — The Health Imperative for a Countermarketing Campaign April 19, 2025
    As the fossil-fuel industry continues to obstruct efforts to curtail pollution from its products, the health community should use strategies that have been effective in fighting other health-harming industries.
    Linda Rudolph, Vishnu Laalitha Surapaneni
  • Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study April 17, 2025
    In a long-term follow-up study, a single dose of fidanacogene elaparvovec was found to lead to sustained factor IX expression in liver cells and dramatically lowered annualized bleeding rates in 14 patients with hemophilia B.
    John E.J. Rasko, Benjamin J. Samelson-Jones, Lindsey A. George, Adam Giermasz, Jonathan M. Ducore, Jerome M. Teitel, Catherine E. McGuinn, Katherine A. High, Ype P. de Jong, Amit Chhabra, Amanda O’Brien, Lynne M. Smith, Ian Winburn, Jeremy Rupon
  • Case 11-2025: A 79-Year-Old Woman with Cough and Weight Loss April 17, 2025
    A 79-year-old woman was evaluated for cough and weight loss. Chest imaging and thoracentesis findings confirmed the presence of an exudative right pleural effusion. A diagnosis was made.
    Leigh H. Simmons, Ryan Willett, J. Erika Haydu, Megan J. Fitzpatrick

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
  • Allergy & Immunology
  • 2021
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
  • Gastroenterology
  • 2021

Previously Published CE Activities

Copyright © 2025. RMEI Medical Education, LLC. All rights reserved​

Privacy | Terms of Use